Cargando…
Enhanced transplantability of human ovarian cancer lines in cyclophosphamide-pretreated nude mice.
Autores principales: | Nauta, M. M., Boven, E., Schlüper, H. M., Erkelens, C. A., Pinedo, H. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1986
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001520/ https://www.ncbi.nlm.nih.gov/pubmed/3017398 |
Ejemplares similares
-
Activity of GR30921X (NSC 382057) and GR63178A (NSC D611615) in human ovarian cancer lines.
por: Boven, E., et al.
Publicado: (1990) -
Comparison of monoclonal antibodies 17-1A and 323/A3: the influence of the affinity on tumour uptake and efficacy of radioimmunotherapy in human ovarian cancer xenografts.
por: Kievit, E., et al.
Publicado: (1996) -
Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.
por: Molthoff, C. F., et al.
Publicado: (1992) -
The anti-tumour effects of the prodrugs N-l-leucyl-doxorubicin and vinblastine-isoleucinate in human ovarian cancer xenografts.
por: Boven, E., et al.
Publicado: (1992) -
Characterization of human soft-tissue sarcoma xenografts for use in secondary drug screening.
por: Boven, E., et al.
Publicado: (1998)